Fast Market Research

Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013 - New Study Released

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

 
Repost This

Boston, MA -- (SBWIRE) -- 02/10/2014 -- Global Market Direct's pharmaceuticals report, "Jeil Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" provides data on the Jeil Pharmaceutical Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Jeil Pharmaceutical Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Jeil Pharmaceutical Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- Jeil Pharmaceutical Co., Ltd. - Brief Jeil Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Jeil Pharmaceutical Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Jeil Pharmaceutical Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Jeil Pharmaceutical Co., Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Jeil Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Jeil Pharmaceutical Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Jeil Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Jeil Pharmaceutical Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Jeil Pharmaceutical Co., Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Jeil Pharmaceutical Co., Ltd.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Chugai Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Simcere Pharmaceutical Group - Product Pipeline Review - 2013
- Mochida Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- BioMarin Pharmaceutical Inc. - Product Pipeline Review - 2013
- La Jolla Pharmaceutical Company - Product Pipeline Review - 2013
- Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2013
- Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Kissei Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013